Jiseon Park

Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.

G. Cho, S. H. Kim, Hee-Jin Kim, 2013, Bioorganic & medicinal chemistry letters.

Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.

G. Cho, S. H. Kim, Min-Young Noh, 2011, Assay and drug development technologies.

Effect of JGK-263 as a new glycogen synthase kinase-3β inhibitor on extrinsic apoptosis pathway in motor neuronal cells.

Yoon-Ho Hong, Kwang-Woo Lee, J. Sung, 2013, Biochemical and biophysical research communications.

Neuroprotective effects of a novel poly (ADP‐ribose) polymerase‐1 inhibitor, JPI‐289, in hypoxic rat cortical neurons

Youngchul Kim, S. H. Kim, Y. S. Kim, 2017, Clinical and experimental pharmacology & physiology.

Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease.

S. Ku, S. H. Kim, Hee-Jin Kim, 2013, Biochemical and biophysical research communications.

Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke

Youngchul Kim, S. H. Kim, Ji Young Kim, 2018, Molecular Neurobiology.

Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).

S. Koh, G. Cho, Seung-Hyun Kim, 2010, Bioorganic & medicinal chemistry letters.

Effects of a newly developed tricyclic PARP‐1 inhibitor, on ischemic stroke

Youngchul Kim, S. Koh, G. Cho, 2010 .

Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke

S. H. Kim, Young Seo Kim, Hyun Young Kim, 2018, Molecular Neurobiology.